Nasdaq: Grifols to seek compensation from Gotham at least equivalent to share loss - board member
BARCELONA, Jan 10 (Reuters) - Spain's pharmaceutical company Grifols will seek a compensation at least equivalent to the share price loss prompted by short seller Gotham City Research's Tuesday report ...
Grifols to seek compensation from Gotham at least equivalent to share loss - board member
MADRID, April 14 (Reuters) - Spanish drug maker Grifols (GRLS.MC), opens new tab, battling a plunge in its share price this year, plans to add independent directors to its audit and compensation ...
The Globe and Mail: Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Yahoo Finance: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
The Corner: Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Link Securities | Grifols (GRF) plans to make an early repayment of €500 million of its 7.5% senior secured bonds maturing in 2030. This transaction would ...
Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...